How to Explore Clinical-Stage Antibody Companies: From Company Screener Search to Clinical Trial Data
- BiopharmIQ
- Jun 12
- 3 min read
Whether you're mapping the antibody development landscape, identifying partnership opportunities, or sourcing leads in immunotherapy, BiopharmIQ makes it easy to find and explore clinical-stage antibody companies—from high-level screening to detailed clinical trial data.
In this quick guide, we’ll walk through how to:
Use the Company Screener to filter for antibody developers
Apply filters for clinical-stage progress
Explore individual company profiles
Jump into clinical trial data for pipeline visibility
Access expanded trial views and exports as a Pro user
Step 1: Start with the Company Screener
From your BiopharmIQ dashboard, click on Company Screener in the left-hand menu. This is your go-to module for filtering across thousands of biopharma companies using rich datasets.
Step 2: Apply Technology and Stage Filters
To find antibody companies in clinical development:
In the Technology Area filter, select Antibodies
In the Most Advanced Clinical Trial Stage filter, choose relevant phases (e.g., Phase 1, Phase 2, Phase 3)
You can also refine by region, disease area, company type, or employee size to target your segment further.
💡 Pro Tip: Combine filters like "Antibodies" + "Oncology" + "Phase 2" to identify highly focused therapeutic developers.
Step 3: Explore the Company Results Table
The results will show a list of matching companies. Each row displays:
Company Name (clickable to access full profile)
Employee Size, Public/Private Status, Location
Company Type & Technology Areas
Step 4: Save the Full Company List (Optional)
Click View Actions above the table and select:
“Save All [x] Companies to New List”
You can revisit this list later via the Saved Lists module. Note that list saving is available to all users, but downloads are available to Pro users with active credit plans.
Step 5: View Clinical Trials on the Company Profile
Click on any company name to open its Company Profile page.
You can scroll to the Pipeline | ClinicalTrials.gov section and view:
Interventions and Indications
Phase & Recruitment Status
Date Posted and ClinicalTrials.gov Source Links (Accessible for PRO users)
💡 Example: For Affibody AB, users can see trials related to HER2-positive breast cancer, along with source-linked NCT IDs.
📊 Clinical Trial Deep Dive for PRO Users
Clicking a NCT source link takes you to a full trial record, where PRO users see:
Study title, phase, sponsor types, enrollment numbers
Intervention arms, endpoints, and eligibility
Study contacts, investigators, and collaborating institutions
💡 Example: One trial using [68Ga]Ga-ABY-025 in HER2-low metastatic breast cancer includes PET-based diagnostics, sponsor details, endpoints like SUVmax correlation with response, and projected completion by 2032.
Step 6: See All Clinical Trials Linked to the Company
Still in the profile, click on "See All" or the Clinical Trials Connect banner to view all trials linked to that company in the Clinical Trials module.
There, you'll get a broader list showing:
Trial status (e.g., Recruiting, Terminated, Completed)
Development Stage, Interventions, and Conditions
Posted Date and More Info icon for expanded view for PRO users
See the Full Clinical Trial Landscape – and Download It
Clicking "See All" in the pipeline section brings PRO users into the Clinical Trials module, filtered to show all trials sponsored by the company.
From there, you can:
Click the More Info icon to view key details on each trial
Use View Actions to:
Download the first 500 clinical trials in the results—no credits needed
Save all/selected trial sponsors to a new list
Set alerts for new trials matching your filters
💬 Final Thoughts
Exploring clinical-stage antibody companies with BiopharmIQ is more than just filtering lists—it’s a seamless path from discovery to trial intelligence. Free users can map opportunities and see trial summaries, while Pro users unlock powerful company data, trial design details, and one-click exports.
Whether you're in BD, scientific strategy, or investment research, BiopharmIQ helps you identify, prioritize, and act on the right opportunities in antibody development—all in one platform.
Comments